02185 BIOHEART-B
Closed Add to PorfolioKey Financial Ratio (Fiscal Year: 12/2024) | |||
Current | 15.22X | Oper Margin | N/A |
---|---|---|---|
LT Debt/Equity | 1.1% | Net Margin | N/A |
Total Debt/Equity | 1.3% | Return on Equity | N/A |
Price/Book | 1.44X | Return on Assets | N/A |
(HKD 4.160) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
Net Profit (MHKD) | -93.53 | -193.87 | -228.99 | -442.09 | -386.33 |
---|---|---|---|---|---|
Net Profit Growth (%) | +51.8 | +15.3 | +48.2 | -14.4 | -1,357.0 |
Earnings Per Share (HKD) | -0.384 | -0.796 | -0.94 | -2.004 | N/A |
Earnings Per Share Growth (%) | +51.8 | +15.2 | +53.1 | +100.0 | N/A |
Dividend Per Share (HKD) | No dividend | No dividend | No dividend | No dividend | No dividend |
P/E* (X) | N/A | N/A | N/A | N/A | N/A |
Yield (%) | N/A | N/A | N/A | N/A | N/A |
Dividend Share (%) | N/A | N/A | N/A | N/A | N/A |
Book NAV (HKD) | 2.880 | 3.382 | 4.060 | 4.992 | N/A |
Auditors' Opinion | Unqualified | Unqualified | Unqualified | Unqualified | N/A |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-07-23 21:40:20
Latest Result
(RMBMn) | 2024-12 | 2023-12 | Chg* (%) | 2022-12 |
Cover Period (mths) | 12 | 12 | NA | 12 |
---|---|---|---|---|
Operating Result | -90.864 | -156.677 | -42.0 | -229.438 |
Associates | -0.986 | -1.633 | -39.6 | -1.43 |
Profit Before Taxation | -93.324 | -188.82 | -50.6 | -230.868 |
Profit /( Loss) After Taxation | -93.324 | -188.82 | -50.6 | -230.868 |
Minority Interests | -5.38 | -12.927 | -58.4 | -26.632 |
Net Profit | -87.944 | -175.893 | -50.0 | -204.236 |
Earnings Per Share () | -0.3842 | -0.7964 | -51.8 | -0.9395 |
Announcement Date | 2025-03-28 | 2024-03-25 | NA | 2023-03-31 |
* Annualised
Last Update Time: 2025-07-23 21:40:25